JAMES SAUNDERS: Open Payments
NPI 1184907289 · DEMING, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$964 in 8 payments from 6 companies in 2025. Trend: 2023 $450 · 2024 $707 · 2025 $964
Food & beverage: $964
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $261 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $250 |
| Janssen Pharmaceuticals, Inc | 1 | $162 |
| E.R. Squibb & Sons, L.L.C. | 1 | $108 |
| Otsuka America Pharmaceutical, Inc. | 1 | $92 |
| Axsome Therapeutics, Inc. | 1 | $91 |
Products named: INGREZZA, CAPLYTA, INVEGA SUSTENNA, COBENFY, ABILIFY MAINTENA, Auvelity.
Industry payments across NM — which companies pay providers there.
